BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD;  Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760-3765. [PMID: 15583079 DOI: 10.1161/01.cir.0000150390.04704.b7] [Cited by in Crossref: 454] [Cited by in F6Publishing: 118] [Article Influence: 26.7] [Reference Citation Analysis]
Number Citing Articles
1 Li SN, Zhang XL, Cai GL, Lin RW, Jiang H, Chen JZ, Xu B, Huang W. Prognostic Significance of Frontal QRS-T Angle in Patients with Idiopathic Dilated Cardiomyopathy. Chin Med J (Engl) 2016;129:1904-11. [PMID: 27503013 DOI: 10.4103/0366-6999.187844] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Maron BJ, Casey SA, Olivotto I, Sherrid MV, Semsarian C, Autore C, Ahmed A, Boriani G, Francia P, Winters SL, Giudici M, Koulova A, Garberich R, Rowin EJ, Sears SF, Maron MS, Spirito P. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Circ Arrhythm Electrophysiol 2018;11:e005820. [PMID: 29625970 DOI: 10.1161/CIRCEP.117.005820] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 10.5] [Reference Citation Analysis]
3 Carbucicchio C, Della Bella P, Fassini G, Trevisi N, Riva S, Giraldi F, Baratto F, Marenzi G, Sisillo E, Bartorelli A. Percutaneous cardiopulmonary support for catheter ablation of unstable ventricular arrhythmias in high-risk patients. Herz. 2009;34:545-552. [PMID: 20091254 DOI: 10.1007/s00059-009-3289-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
4 Pontone G, Guaricci AI, Andreini D, Solbiati A, Guglielmo M, Mushtaq S, Baggiano A, Beltrama V, Fusini L, Rota C, Segurini C, Conte E, Gripari P, Dello Russo A, Moltrasio M, Tundo F, Lombardi F, Muscogiuri G, Lorenzoni V, Tondo C, Agostoni P, Bartorelli AL, Pepi M. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter–Defibrillator Therapy. Circ: Cardiovascular Imaging 2016;9. [DOI: 10.1161/circimaging.115.004956] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
5 Looi KL, Gavin A, Cooper L, Dawson L, Slipper D, Lever N. Outcomes of patients with heart failure after primary prevention ICD unit generator replacement. Heart Asia 2019;11:e011162. [PMID: 31031836 DOI: 10.1136/heartasia-2018-011162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Santini M, Russo M, Botto G, Lunati M, Proclemer A, Schmidt B, Erdogan A, Helmling E, Rauhe W, Desaga M, Santi E, Messier M, Boriani G. Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 2009;11:476-82. [PMID: 19136492 DOI: 10.1093/europace/eun349] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
7 Metra M, Eichhorn E, Abraham WT, Linseman J, Böhm M, Corbalan R, DeMets D, De Marco T, Elkayam U, Gerber M. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. Eur Heart J. 2009;30:3015-3026. [PMID: 19700774 DOI: 10.1093/eurheartj/ehp338] [Cited by in Crossref: 86] [Cited by in F6Publishing: 69] [Article Influence: 8.6] [Reference Citation Analysis]
8 Chery G, Kamp N, Kosinski AS, Schmidler GS, Lopes RD, Patel M, Al-Khatib SM. Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review. Am Heart J 2020;229:52-60. [PMID: 32916608 DOI: 10.1016/j.ahj.2020.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Dickfeld T. Pursuing the "Holy Grail". Circ Cardiovasc Imaging 2012;5:167-70. [PMID: 22438421 DOI: 10.1161/CIRCIMAGING.112.972935] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Willems S, Tilz RR, Steven D, Kääb S, Wegscheider K, Gellér L, Meyer C, Heeger C, Metzner A, Sinner MF, Schlüter M, Nordbeck P, Eckardt L, Bogossian H, Sultan A, Wenzel B, Kuck K, Piorkowski C, Lebedev D, Kautzner J, Sticherling C, Deneke T, Rostock T, Ukena C, Kuniss M, Makimoto H, Hindricks G, Bänsch D, Schreieck J, Kolb C, Geller J, Pokushalov E, Gutleben K, Sommer P, Boldt L, Parwani A. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial. Circulation 2020;141:1057-67. [DOI: 10.1161/circulationaha.119.043400] [Cited by in Crossref: 25] [Cited by in F6Publishing: 3] [Article Influence: 25.0] [Reference Citation Analysis]
11 Yang SJ, Huh JW, Lee JE, Choi SY, Kim TU, Cho SW. Inactivation of human glutamate dehydrogenase by aluminum. Cell Mol Life Sci 2003;60:2538-46. [PMID: 14625697 DOI: 10.1007/s00018-003-3298-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
12 Klein T, Dilsizian V, Cao Q, Chen W, Dickfeld TM. The potential role of iodine-123 metaiodobenzylguanidine imaging for identifying sustained ventricular tachycardia in patients with cardiomyopathy. Curr Cardiol Rep 2013;15:359. [PMID: 23536110 DOI: 10.1007/s11886-013-0359-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
13 Dorian P, Hohnloser SH, Thorpe KE, Roberts RS, Kuck K, Gent M, Connolly SJ. Mechanisms Underlying the Lack of Effect of Implantable Cardioverter-Defibrillator Therapy on Mortality in High-Risk Patients With Recent Myocardial Infarction: Insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT). Circulation 2010;122:2645-52. [DOI: 10.1161/circulationaha.109.924225] [Cited by in Crossref: 100] [Cited by in F6Publishing: 11] [Article Influence: 9.1] [Reference Citation Analysis]
14 Voulgari C, Pagoni S, Tesfaye S, Tentolouris N. The spatial QRS-T angle: implications in clinical practice. Curr Cardiol Rev. 2013;9:197-210. [PMID: 23909632 DOI: 10.2174/1573403x113099990031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
15 de Haan S, Rijnierse MT, Harms HJ, Verberne HJ, Lammertsma AA, Huisman MC, Windhorst AD, van Rossum AC, Allaart CP, Knaapen P. Myocardial denervation coincides with scar heterogeneity in ischemic cardiomyopathy: A PET and CMR study. J Nucl Cardiol 2016;23:1480-8. [PMID: 26553060 DOI: 10.1007/s12350-015-0316-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Tang PT, Do DH, Li A, Boyle NG. Team Management of the Ventricular Tachycardia Patient. Arrhythm Electrophysiol Rev 2018;7:238-46. [PMID: 30588311 DOI: 10.15420/aer.2018.37.2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Greenlee RT, Go AS, Peterson PN, Cassidy-Bushrow AE, Gaber C, Garcia-Montilla R, Glenn KA, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Kadish A, Magid DJ, McManus DD, Multerer D, Powers JD, Reifler LM, Reynolds K, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Masoudi FA. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network. J Am Heart Assoc 2018;7:e008292. [PMID: 29581222 DOI: 10.1161/JAHA.117.008292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
18 Vaidya VR, Desimone CV, Madhavan M, Noheria A, Shahid M, Walters J, Ladewig DJ, Mikell SB, Johnson SB, Suddendorf SH, Asirvatham SJ. Compatibility of electroanatomical mapping systems with a concurrent percutaneous axial flow ventricular assist device. J Cardiovasc Electrophysiol 2014;25:781-6. [PMID: 24758340 DOI: 10.1111/jce.12437] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
19 Malhotra S, Fernandez SF, Fallavollita JA, Canty JM Jr. Prognostic Significance of Imaging Myocardial Sympathetic Innervation. Curr Cardiol Rep 2015;17:62. [PMID: 26087899 DOI: 10.1007/s11886-015-0613-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
20 Zarraga IGE, Dougherty CM, Macmurdy KS, Raitt MH. The Effect of Spironolactone on Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators. Circ Arrhythm Electrophysiol 2012;5:739-47. [DOI: 10.1161/circep.112.970566] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
21 Werner RA, Chen X, Hirano M, Rowe SP, Lapa C, Javadi MS, Higuchi T. SPECT vs. PET in cardiac innervation imaging: clash of the titans. Clin Transl Imaging 2018;6:293-303. [PMID: 30148120 DOI: 10.1007/s40336-018-0289-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
22 Friedman DJ, Altman RK, Orencole M, Picard MH, Ruskin JN, Singh JP, Heist EK. Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2012;5:762-72. [PMID: 22787010 DOI: 10.1161/CIRCEP.112.971101] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
23 Chowdhury SK, Liu W, Zi M, Li Y, Wang S, Tsui H, Prehar S, Castro S, Zhang H, Ji Y, Zhang X, Xiao R, Zhang R, Lei M, Cyganek L, Guan K, Millar CB, Liao X, Jain MK, Boyett MR, Cartwright EJ, Shiels HA, Wang X. Stress-Activated Kinase Mitogen-Activated Kinase Kinase-7 Governs Epigenetics of Cardiac Repolarization for Arrhythmia Prevention. Circulation. 2017;135:683-699. [PMID: 27899394 DOI: 10.1161/circulationaha.116.022941] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
24 Poole JE, Gold MR. Who Should Receive the Subcutaneous Implanted Defibrillator?: The Subcutaneous Implantable Cardioverter Defibrillator (ICD) Should Be Considered in all ICD Patients Who Do Not Require Pacing. Circ: Arrhythmia and Electrophysiology 2013;6:1236-45. [DOI: 10.1161/circep.113.000481] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 3.9] [Reference Citation Analysis]
25 Yousuf O, Chrispin J, Tomaselli GF, Berger RD. Clinical management and prevention of sudden cardiac death. Circ Res 2015;116:2020-40. [PMID: 26044254 DOI: 10.1161/CIRCRESAHA.116.304555] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 6.2] [Reference Citation Analysis]
26 Li A, Kaura A, Sunderland N, Dhillon PS, Scott PA. The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients. Arrhythm Electrophysiol Rev 2016;5:110-6. [PMID: 27617089 DOI: 10.15420/AER.2016.12.2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
27 Al Badarin FJ, Wimmer AP, Kennedy KF, Jacobson AF, Bateman TM. The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy. J Nucl Cardiol 2014;21:756-62; quiz 753-55, 763-5. [PMID: 25015681 DOI: 10.1007/s12350-014-9919-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
28 Piccini JP, Hellkamp AS, Whellan DJ, Ellis SJ, Keteyian SJ, Kraus WE, Hernandez AF, Daubert JP, Piña lL, O'Connor CM; HF-ACTION Investigators. Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing). JACC Heart Fail 2013;1:142-8. [PMID: 23936756 DOI: 10.1016/j.jchf.2013.01.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
29 Kwon DH, Asamoto L, Popovic ZB, Kusunose K, Robinson M, Desai M, Marwick TH, Flamm SD. Infarct characterization and quantification by delayed enhancement cardiac magnetic resonance imaging is a powerful independent and incremental predictor of mortality in patients with advanced ischemic cardiomyopathy. Circ Cardiovasc Imaging 2014;7:796-804. [PMID: 25085923 DOI: 10.1161/CIRCIMAGING.114.002077] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 3.9] [Reference Citation Analysis]
30 Chinyere IR, Moukabary T, Hutchinson MD, Lancaster JJ, Juneman E, Goldman S. Progression of infarct-mediated arrhythmogenesis in a rodent model of heart failure. Am J Physiol Heart Circ Physiol 2021;320:H108-16. [PMID: 33164577 DOI: 10.1152/ajpheart.00639.2020] [Reference Citation Analysis]
31 Hohnloser SH, Israel CW. Current evidence base for use of the implantable cardioverter-defibrillator. Circulation. 2013;128:172-183. [PMID: 23836830 DOI: 10.1161/circulationaha.112.000547] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
32 Borleffs CJW, Scherptong RW, Man S, van Welsenes GH, Bax JJ, van Erven L, Swenne CA, Schalij MJ. Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease: Clinical Application of the ECG-Derived QRS-T Angle. Circ Arrhythm Electrophysiol 2009;2:548-54. [DOI: 10.1161/circep.109.859108] [Cited by in Crossref: 84] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
33 Pokorney SD, Friedman DJ, Calkins H, Callans DJ, Daoud EG, Della-Bella P, Jackson KP, Shivkumar K, Saba S, Sapp J, Stevenson WG, Al-Khatib SM. Catheter ablation of ventricular tachycardia: Lessons learned from past clinical trials and implications for future clinical trials. Heart Rhythm 2016;13:1748-54. [PMID: 27050910 DOI: 10.1016/j.hrthm.2016.04.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
34 Rijnierse MT, de Haan S, Harms HJ, Robbers LF, Wu L, Danad I, Beek AM, Heymans MW, van Rossum AC, Lammertsma AA, Allaart CP, Knaapen P. Impaired Hyperemic Myocardial Blood Flow Is Associated With Inducibility of Ventricular Arrhythmia in Ischemic Cardiomyopathy. Circ: Cardiovascular Imaging 2014;7:20-30. [DOI: 10.1161/circimaging.113.001158] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
35 Moss AJ. Heart failure: a central factor in progressive mechanical and electrical cardiac dysfunction. Ann Noninvasive Electrocardiol 2005;10:279-80. [PMID: 16029377 DOI: 10.1111/j.1542-474X.2005.20050711.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Sweeney MO. The Contradiction of Appropriate Shocks in Primary Prevention ICDs: Increasing and Decreasing the Risk of Death. Circulation 2010;122:2638-41. [DOI: 10.1161/circulationaha.110.000208] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
37 Segreti L, Di Cori A, Zucchelli G, Soldati E, Coluccia G, Viani S, Paperini L, Bongiorni MG. A Questionable Indication For ICD Extraction After Successful VT Ablation. J Atr Fibrillation 2015;7:1172. [PMID: 27957158 DOI: 10.4022/jafib.1172] [Reference Citation Analysis]
38 Wuest S, Twerenbold R, Kühne M, Reichlin T, Sticherling C, Osswald S, Schaer B. Reassessment of cardiovascular parameters and comorbidities in implantable cardioverter-defibrillator patients at the time of first replacement. Clin Cardiol 2018;41:57-62. [PMID: 29355999 DOI: 10.1002/clc.22849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Revenco D, Morgan JP, Tsao L. The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population. J Geriatr Cardiol 2011;8:195-200. [PMID: 22783305 DOI: 10.3724/SP.J.1263.2011.00195] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
40 De Vincentis G, Frantellizzi V, Fedele F, Farcomeni A, Scarparo P, Salvi N, Fegatelli DA, Mancone M, Verschure DO, Verberne HJ. Role of cardiac 123I-mIBG imaging in predicting arrhythmic events in stable chronic heart failure patients with an ICD. J Nucl Cardiol 2019;26:1188-96. [PMID: 29594915 DOI: 10.1007/s12350-018-1258-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
41 Elayi CS, Charnigo RJ, Heron PM, Lee BK, Olgin JE. Primary Prevention of Sudden Cardiac Death Early Post-Myocardial Infarction: Root Cause Analysis for Implantable Cardioverter–Defibrillator Failure and Currently Available Options. Circ: Arrhythmia and Electrophysiology 2017;10. [DOI: 10.1161/circep.117.005194] [Cited by in Crossref: 11] [Article Influence: 2.8] [Reference Citation Analysis]
42 Fang Y, Gu K, Yang B, Ju W, Chen H, Li M, Liu H, Wang J, Yang G, Chen M. What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?-Results from over 1000 episodes. J Arrhythm 2018;34:36-45. [PMID: 29721112 DOI: 10.1002/joa3.12010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Callum K, Graune C, Bowman E, Molden E, Leslie SJ. Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area. World J Cardiol 2021;13:46-54. [PMID: 33791078 DOI: 10.4330/wjc.v13.i3.46] [Reference Citation Analysis]
44 Toh N, Nishii N, Nakamura K, Tada T, Oe H, Nagase S, Kohno K, Morita H, Kusano KF, Ito H. Cardiac dysfunction and prolonged hemodynamic deterioration after implantable cardioverter-defibrillator shock in patients with systolic heart failure. Circ Arrhythm Electrophysiol 2012;5:898-905. [PMID: 22837155 DOI: 10.1161/CIRCEP.111.970285] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
45 Sacher F, Tedrow UB, Field ME, Raymond J, Koplan BA, Epstein LM, Stevenson WG. Ventricular Tachycardia Ablation: Evolution of Patients and Procedures Over 8 Years. Circ Arrhythm Electrophysiol 2008;1:153-61. [DOI: 10.1161/circep.108.769471] [Cited by in Crossref: 130] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
46 Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD, O'Brien MC, Weintraub WS. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol 2009;32:1259-71. [PMID: 19796343 DOI: 10.1111/j.1540-8159.2009.02495.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
47 Tereshchenko LG, Faddis MN, Fetics BJ, Zelik KE, Efimov IR, Berger RD. Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression. J Am Coll Cardiol 2009;54:822-8. [PMID: 19695461 DOI: 10.1016/j.jacc.2009.06.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
48 Friehling M, Soman P. Newer applications of nuclear cardiology in systolic heart failure: detecting coronary artery disease and guiding device therapy. Curr Heart Fail Rep. 2011;8:106-112. [PMID: 21465127 DOI: 10.1007/s11897-011-0057-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation. 2006;113:776-782. [PMID: 16461817 DOI: 10.1161/circulationaha.105.561571] [Cited by in Crossref: 240] [Cited by in F6Publishing: 56] [Article Influence: 16.0] [Reference Citation Analysis]
50 Hess PL, Laird A, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Hall WJ, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Al-Khatib SM, Piccini JP, Inoue LY, Sanders GD. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm 2013;10:828-35. [PMID: 23416381 DOI: 10.1016/j.hrthm.2013.02.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
51 Zelt JGE, Wang JZ, Mielniczuk LM, Beanlands RSB, Fallavollita JA, Canty JM Jr, deKemp RA. Positron Emission Tomography Imaging of Regional Versus Global Myocardial Sympathetic Activity to Improve Risk Stratification in Patients With Ischemic Cardiomyopathy. Circ Cardiovasc Imaging 2021;14:e012549. [PMID: 34102857 DOI: 10.1161/CIRCIMAGING.121.012549] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Rizas KD, McNitt S, Hamm W, Massberg S, Kääb S, Zareba W, Couderc JP, Bauer A. Prediction of sudden and non-sudden cardiac death in post-infarction patients with reduced left ventricular ejection fraction by periodic repolarization dynamics: MADIT-II substudy. Eur Heart J 2017;38:2110-8. [PMID: 28431133 DOI: 10.1093/eurheartj/ehx161] [Cited by in Crossref: 44] [Cited by in F6Publishing: 17] [Article Influence: 14.7] [Reference Citation Analysis]
53 Salmoirago-Blotcher E, Crawford SL, Carmody J, Rosenthal L, Yeh G, Stanley M, Rose K, Browning C, Ockene IS. Phone-delivered mindfulness training for patients with implantable cardioverter defibrillators: results of a pilot randomized controlled trial. Ann Behav Med 2013;46:243-50. [PMID: 23605175 DOI: 10.1007/s12160-013-9505-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
54 Eckardt L, Breithardt G. Catheter ablation of ventricular tachycardia. From indication to three-dimensional mapping technology. Herz 2009;34:187-96. [PMID: 19444402 DOI: 10.1007/s00059-009-3247-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
55 Rosenbaum DS. T-wave alternans in the sudden cardiac death in heart failure trial population: signal or noise? Circulation 2008;118:2015-8. [PMID: 19001031 DOI: 10.1161/CIRCULATIONAHA.108.818286] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
56 Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders G. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circ Cardiovasc Qual Outcomes 2015;8:179-86. [PMID: 25669833 DOI: 10.1161/CIRCOUTCOMES.114.001306] [Cited by in Crossref: 68] [Cited by in F6Publishing: 15] [Article Influence: 11.3] [Reference Citation Analysis]
57 Alexandre J, Saloux E, Dugué AE, Lebon A, Lemaitre A, Roule V, Labombarda F, Provost N, Gomes S, Scanu P. Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease. J Cardiovasc Magn Reson. 2013;15:12. [PMID: 23331500 DOI: 10.1186/1532-429x-15-12] [Cited by in Crossref: 43] [Cited by in F6Publishing: 13] [Article Influence: 5.4] [Reference Citation Analysis]
58 Mustafa U, Dherange P, Reddy R, DeVillier J, Chong J, Ihsan A, Jones R, Duddyala N, Reddy P, Dominic P. Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7:e010156. [PMID: 30554547 DOI: 10.1161/JAHA.118.010156] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
59 Ghislandi S, Torbica A, Boriani G. Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data. BMC Health Serv Res 2013;13:100. [PMID: 23496994 DOI: 10.1186/1472-6963-13-100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
60 Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, Koethe BC, Romashko M, Link MS, Maron BJ. Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol 2019;4:644-57. [PMID: 31116360 DOI: 10.1001/jamacardio.2019.1391] [Cited by in Crossref: 99] [Cited by in F6Publishing: 67] [Article Influence: 99.0] [Reference Citation Analysis]
61 Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV. Impact of Programming Strategies Aimed at Reducing Nonessential Implantable Cardioverter Defibrillator Therapies on Mortality: A Systematic Review and Meta-Analysis. Circ Arrhythm Electrophysiol 2014;7:164-70. [DOI: 10.1161/circep.113.001217] [Cited by in Crossref: 83] [Cited by in F6Publishing: 12] [Article Influence: 11.9] [Reference Citation Analysis]
62 Thijssen J, Borleffs CJ, van Rees JB, de Bie MK, van der Velde ET, van Erven L, Bax JJ, Cannegieter SC, Schalij MJ. Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach. Eur Heart J 2011;32:2678-87. [PMID: 21646229 DOI: 10.1093/eurheartj/ehr161] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
63 Lewandowski M, Przybylski A, Kuźmicz W, Szwed H. Reduction of the inappropriate ICD therapies by implementing a new fuzzy logic-based diagnostic algorithm. Ann Noninvasive Electrocardiol 2013;18:457-66. [PMID: 24047490 DOI: 10.1111/anec.12090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Hindricks G, Elsner C, Piorkowski C, Taborsky M, Geller JC, Schumacher B, Bytesnik J, Kottkamp H. Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial. Eur Heart J 2014;35:98-105. [PMID: 23868932 DOI: 10.1093/eurheartj/eht207] [Cited by in Crossref: 49] [Cited by in F6Publishing: 25] [Article Influence: 6.1] [Reference Citation Analysis]
65 Parkash R, Nault I, Rivard L, Gula L, Essebag V, Nery P, Tung S, Raymond JM, Sterns L, Doucette S, Wells G, Tang ASL, Stevenson WG, Sapp JL. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease). Circ Arrhythm Electrophysiol 2018;11:e005663. [PMID: 29305400 DOI: 10.1161/CIRCEP.117.005663] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
66 Curtis AB, Karki R, Hattoum A, Sharma UC. Arrhythmias in Patients ≥80 Years of Age: Pathophysiology, Management, and Outcomes. J Am Coll Cardiol 2018;71:2041-57. [PMID: 29724357 DOI: 10.1016/j.jacc.2018.03.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
67 Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death. Circ Arrhythm Electrophysiol 2016;9:e003283. [PMID: 26921377 DOI: 10.1161/CIRCEP.115.003283] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 6.8] [Reference Citation Analysis]
68 Aktaş MK, Younis A, Zareba W, Kutyifa V, Klein H, Daubert JP, Estes M, McNitt S, Polonsky B, Goldenberg I. Survival After Implantable Cardioverter-Defibrillator Shocks. J Am Coll Cardiol 2021;77:2453-62. [PMID: 34016257 DOI: 10.1016/j.jacc.2021.03.329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 AbdelWahab A, Sapp J. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. Curr Cardiol Rep 2017;19:105. [PMID: 28900864 DOI: 10.1007/s11886-017-0924-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
70 Stempniewicz P, Cheng A, Connolly A, Wang XY, Calkins H, Tomaselli GF, Berger RD, Tereshchenko LG. Appropriate and inappropriate electrical therapies delivered by an implantable cardioverter-defibrillator: effect on intracardiac electrogram. J Cardiovasc Electrophysiol 2011;22:554-60. [PMID: 21087331 DOI: 10.1111/j.1540-8167.2010.01958.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
71 Stevenson LW. Implantable cardioverter-defibrillators for primary prevention of sudden death in heart failure: are there enough bangs for the bucks? Circulation 2006;114:101-3. [PMID: 16831996 DOI: 10.1161/CIRCULATIONAHA.106.637405] [Cited by in Crossref: 39] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
72 Smith T, van Dessel PF, Theuns DA, Muskens-Heemskerk A, van Domburg RT, Wilde AA, Jordaens L. Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Neth Heart J 2011;19:405-11. [PMID: 21773744 DOI: 10.1007/s12471-011-0176-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
73 Stewart GC, Weintraub JR, Pratibhu PP, Semigran MJ, Camuso JM, Brooks K, Tsang SW, Anello MS, Nguyen VT, Lewis EF, Nohria A, Desai AS, Givertz MM, Stevenson LW. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail 2010;16:106-13. [PMID: 20142021 DOI: 10.1016/j.cardfail.2009.09.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 64] [Article Influence: 7.6] [Reference Citation Analysis]
74 Radinovic A, Baratto F, Della Bella P. Optimal Timing of VT Ablation for Patients with ICD Therapies. Curr Cardiol Rep 2020;22:91. [PMID: 32648057 DOI: 10.1007/s11886-020-01345-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, Dicarlo L, Feldman AM, Galle E, Ecklund F. Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006;114:2766-72. [DOI: 10.1161/circulationaha.106.642892] [Cited by in Crossref: 210] [Cited by in F6Publishing: 50] [Article Influence: 14.0] [Reference Citation Analysis]
76 Bax JJ, Delgado V. Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol 2015;22:229-45. [PMID: 25733105 DOI: 10.1007/s12350-015-0096-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
77 Reinier K, Narayanan K, Uy-Evanado A, Teodorescu C, Chugh H, Mack WJ, Gunson K, Jui J, Chugh SS. Electrocardiographic Markers and the Left Ventricular Ejection Fraction have Cumulative Effects on Risk of Sudden Cardiac Death. JACC Clin Electrophysiol 2015;1:542-50. [PMID: 26949741 DOI: 10.1016/j.jacep.2015.07.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
78 Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-65. [PMID: 18160685 DOI: 10.1056/NEJMoa065457] [Cited by in Crossref: 591] [Cited by in F6Publishing: 88] [Article Influence: 45.5] [Reference Citation Analysis]
79 Madhavan M, Friedman PA. Optimal Programming of Implantable Cardiac-Defibrillators. Circulation 2013;128:659-72. [DOI: 10.1161/circulationaha.112.000542] [Cited by in Crossref: 32] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
80 Bertini M, Schalij MJ, Bax JJ, Delgado V. Emerging role of multimodality imaging to evaluate patients at risk for sudden cardiac death. Circ Cardiovasc Imaging 2012;5:525-35. [PMID: 22811416 DOI: 10.1161/CIRCIMAGING.110.961532] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
81 Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S. Death Without Prior Appropriate Implantable Cardioverter-Defibrillator Therapy: A Competing Risk Study. Circulation 2008;117:1918-26. [DOI: 10.1161/circulationaha.107.742155] [Cited by in Crossref: 92] [Cited by in F6Publishing: 26] [Article Influence: 7.1] [Reference Citation Analysis]
82 Streitner F, Herrmann T, Kuschyk J, Lang S, Doesch C, Papavassiliu T, Streitner I, Veltmann C, Haghi D, Borggrefe M. Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention. PLoS One 2013;8:e63911. [PMID: 23675514 DOI: 10.1371/journal.pone.0063911] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
83 Biessmann H, Mason JM. Telomerase-independent mechanisms of telomere elongation. Cell Mol Life Sci 2003;60:2325-33. [PMID: 14625679 DOI: 10.1007/s00018-003-3247-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
84 Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P, Klein GJ, Stirrat J, Fine N, Pallaveshi L. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging. 2012;5:448-456. [PMID: 22572740 DOI: 10.1161/circimaging.111.971549] [Cited by in Crossref: 147] [Cited by in F6Publishing: 54] [Article Influence: 16.3] [Reference Citation Analysis]
85 Fallavollita JA, Dare JD, Carter RL, Baldwa S, Canty JM. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality. Circ Cardiovasc Imaging. 2017;10. [PMID: 28794139 DOI: 10.1161/circimaging.117.006446] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
86 Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T, Gonzalez MD, Worley SJ, Daoud EG, Hwang C, Schuger C, Bump TE, Jazayeri M, Tomassoni GF, Kopelman HA, Soejima K, Nakagawa H. Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction: The Multicenter Thermocool Ventricular Tachycardia Ablation Trial. Circulation 2008;118:2773-82. [DOI: 10.1161/circulationaha.108.788604] [Cited by in Crossref: 519] [Cited by in F6Publishing: 127] [Article Influence: 39.9] [Reference Citation Analysis]
87 Delgado V, Bucciarelli-Ducci C, Bax JJ. Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonance. J Nucl Cardiol 2016;23:1399-410. [PMID: 27473216 DOI: 10.1007/s12350-016-0595-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
88 Sardu C, Santamaria M, Rizzo MR, Barbieri M, di Marino M, Paolisso G, Santulli G, Marfella R. Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study. Int J Clin Pract 2016;70:569-76. [PMID: 27291327 DOI: 10.1111/ijcp.12823] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 8.6] [Reference Citation Analysis]
89 Wei C, Qian P, Tedrow U, Mak R, Zei PC. Non-invasive Stereotactic Radioablation: A New Option for the Treatment of Ventricular Arrhythmias. Arrhythm Electrophysiol Rev 2020;8:285-93. [PMID: 32685159 DOI: 10.15420/aer.2019.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
90 Murray K, Buttigieg K, Todd M, McKechnie V. Delivering an efficient and effective support group for patients with implantable cardioverter-defibrillators (ICDs): patient perspectives of key concerns and predictors of inclination to attend. BMC Health Serv Res 2021;21:745. [PMID: 34315446 DOI: 10.1186/s12913-021-06735-3] [Reference Citation Analysis]
91 Stevenson WG, Soejima K. Catheter ablation for ventricular tachycardia. Circulation 2007;115:2750-60. [PMID: 17533195 DOI: 10.1161/CIRCULATIONAHA.106.655720] [Cited by in Crossref: 204] [Cited by in F6Publishing: 46] [Article Influence: 14.6] [Reference Citation Analysis]
92 Kammoun I, Bennour E, Laroussi L, Miled M, Sghaier A, Rahma K, Amine B, Marrakchi S, Kachboura S. Risk stratification for sudden cardiac death in patients with heart failure : Emerging role of imaging parameters. Herz 2021. [PMID: 33909114 DOI: 10.1007/s00059-021-05032-3] [Reference Citation Analysis]
93 Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH. Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 2006;17:940-3. [PMID: 16948736 DOI: 10.1111/j.1540-8167.2006.00550.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
94 Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation. 2010;121:445-456. [PMID: 20100987 DOI: 10.1161/circulationaha.109.878579] [Cited by in Crossref: 211] [Cited by in F6Publishing: 52] [Article Influence: 19.2] [Reference Citation Analysis]
95 Zaman S, Kovoor P. Sudden cardiac death early after myocardial infarction: pathogenesis, risk stratification, and primary prevention. Circulation 2014;129:2426-35. [PMID: 24914016 DOI: 10.1161/CIRCULATIONAHA.113.007497] [Cited by in Crossref: 55] [Cited by in F6Publishing: 13] [Article Influence: 7.9] [Reference Citation Analysis]
96 Jablonowski R, Chaudhry U, van der Pals J, Engblom H, Arheden H, Heiberg E, Wu KC, Borgquist R, Carlsson M. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods. Circ Cardiovasc Imaging 2017;10:e006105. [PMID: 28838961 DOI: 10.1161/CIRCIMAGING.116.006105] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
97 Fallavollita JA, Heavey BM, Luisi AJ, Michalek SM, Baldwa S, Mashtare TL, Hutson AD, Dekemp RA, Haka MS, Sajjad M, Cimato TR, Curtis AB, Cain ME, Canty JM. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2014;63:141-149. [PMID: 24076296 DOI: 10.1016/j.jacc.2013.07.096] [Cited by in Crossref: 268] [Cited by in F6Publishing: 152] [Article Influence: 33.5] [Reference Citation Analysis]
98 Dichtl W, Wolber T, Paoli U, Brüllmann S, Stühlinger M, Berger T, Spuller K, Strasak A, Pachinger O, Haegeli LM, Duru F, Hintringer F. Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients. Clin Cardiol 2011;34:433-6. [PMID: 21678454 DOI: 10.1002/clc.20910] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
99 Verschure DO, van Eck-Smit BL, Somsen GA, Knol RJ, Verberne HJ. Cardiac sympathetic activity in chronic heart failure: cardiac 123I-mIBG scintigraphy to improve patient selection for ICD implantation. Neth Heart J 2016;24:701-8. [PMID: 27677744 DOI: 10.1007/s12471-016-0902-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
100 Mikami Y, Jolly U, Heydari B, Peng M, Almehmadi F, Zahrani M, Bokhari M, Stirrat J, Lydell CP, Howarth AG, Yee R, White JA. Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction. Circ: Arrhythmia and Electrophysiology 2017;10. [DOI: 10.1161/circep.116.004067] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
101 Salmoirago-Blotcher E, Ockene IS. Methodological limitations of psychosocial interventions in patients with an implantable cardioverter-defibrillator (ICD) A systematic review. BMC Cardiovasc Disord 2009;9:56. [PMID: 20040100 DOI: 10.1186/1471-2261-9-56] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
102 Sweeney MO. The Implantable Cardioverter-Defibrillator Minimalist: An Approach to Patient Follow-Up and Management of Implantable Defibrillators. Circulation 2012;126:369-77. [DOI: 10.1161/circulationaha.111.023887] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
103 Elayi CS, Whitbeck MG, Charnigo R, Shah J, Macaulay TE, Morales G, Gurley JC, Kakavand B, Thal S, Ching CK. Is there an association between external cardioversions and long-term mortality and morbidity? Insights from the Atrial Fibrillation Follow-up Investigation of Rhythm Management study. Circ Arrhythm Electrophysiol. 2011;4:465-469. [PMID: 21511994 DOI: 10.1161/circep.110.960591] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
104 Stevenson WG, Tedrow UB. Ablation for ventricular tachycardia during stable sinus rhythm. Circulation 2012;125:2175-7. [PMID: 22492579 DOI: 10.1161/CIRCULATIONAHA.112.107458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
105 Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017. [PMID: 18768944 DOI: 10.1056/nejmoa071098] [Cited by in Crossref: 1015] [Cited by in F6Publishing: 151] [Article Influence: 78.1] [Reference Citation Analysis]
106 Buckberg G, Athanasuleas C, Conte J. Surgical ventricular restoration for the treatment of heart failure. Nat Rev Cardiol 2012;9:703-16. [PMID: 23149831 DOI: 10.1038/nrcardio.2012.143] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
107 Janardhan AH, Li W, Fedorov VV, Yeung M, Wallendorf MJ, Schuessler RB, Efimov IR. A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails. J Am Coll Cardiol 2012;60:2393-8. [PMID: 23141483 DOI: 10.1016/j.jacc.2012.08.1001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
108 Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging. 2009;2:183-190. [PMID: 19808591 DOI: 10.1161/circimaging.108.826529] [Cited by in Crossref: 328] [Cited by in F6Publishing: 109] [Article Influence: 27.3] [Reference Citation Analysis]
109 DeMazumder D, Limpitikul WB, Dorante M, Dey S, Mukhopadhyay B, Zhang Y, Moorman JR, Cheng A, Berger RD, Guallar E, Jones SR, Tomaselli GF. Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death. Europace 2016;18:1818-28. [PMID: 27044982 DOI: 10.1093/europace/euv399] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
110 Barletta V, Fabiani I, Lorenzo C, Nicastro I, Bello VD. Sudden Cardiac Death: A Review Focused on Cardiovascular Imaging. J Cardiovasc Echogr 2014;24:41-51. [PMID: 28465902 DOI: 10.4103/2211-4122.135611] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Chung ES, Dan D, Solomon SD, Bank AJ, Pastore J, Iyer A, Berger RD, Franklin JO, Jones G, Machado C, Stolen CM. Effect of Peri-Infarct Pacing Early After Myocardial Infarction: Results of the Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study. Circ Heart Fail 2010;3:650-8. [DOI: 10.1161/circheartfailure.110.945881] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
112 van Barreveld M, Dijkgraaf MGW, Hulleman M, Boersma LVA, Delnoy PPHM, Meine M, Tuinenburg AE, Theuns DAMJ, van der Voort PH, Kimman GP, Buskens E, Tijssen JPG, Bruinsma N, Verstraelen TE, Zwinderman AH, van Dessel PHFM, Wilde AAM; DO-IT investigators. Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator. Neth Heart J 2017;25:574-80. [PMID: 28785868 DOI: 10.1007/s12471-017-1016-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
113 Zhou Y, Zhao S, Chen K, Hua W, Su Y, Chen S, Liang Z, Xu W, Zhang S. Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients. BMC Cardiovasc Disord 2019;19:230. [PMID: 31638918 DOI: 10.1186/s12872-019-1218-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Tamaki N, Yoshinaga K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol 2011;18:135-43. [PMID: 21082300 DOI: 10.1007/s12350-010-9305-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
115 Theuns DA, Schaer BA, Soliman OI, Altmann D, Sticherling C, Geleijnse ML, Osswald S, Jordaens L. The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace 2011;13:62-9. [PMID: 20833692 DOI: 10.1093/europace/euq328] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
116 Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 2010;122:2359-67. [PMID: 21098452 DOI: 10.1161/CIRCULATIONAHA.110.960633] [Cited by in Crossref: 370] [Cited by in F6Publishing: 73] [Article Influence: 33.6] [Reference Citation Analysis]
117 Alzand BS, Timmermans CC, Wellens HJ, Dennert R, Philippens SA, Portegijs PJ, Rodriguez LM. Unmappable ventricular tachycardia after an old myocardial infarction. Long-term results of substrate modification in patients with an implantable cardioverter defibrillator. J Interv Card Electrophysiol. 2011;31:149-156. [PMID: 21340515 DOI: 10.1007/s10840-011-9549-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
118 Almendral J, Josephson ME. All Patients With Hemodynamically Tolerated Postinfarction Ventricular Tachycardia Do Not Require an Implantable Cardioverter-Defibrillator. Circulation 2007;116:1204-12. [DOI: 10.1161/circulationaha.106.670067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]